FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293740503> ?p ?o ?g. }

• W4293740503 abstract "Background: The effect of herbal medicine (HM) on amyotrophic lateral sclerosis (ALS) is controversial. Clinical trials investigating HMs continue; however, the use of HM is still questioned. We aimed to systematically review the literature pertaining to the effects and safety of HM in ALS. Methods: Randomised controlled trials (RCTs) that investigated the efficacy of HMs in ALS patients compared to any types of controls were identified. Nine databases and six registers were searched from their inception dates to 25 March 2022. Per the PRISMA guidelines, trials were identified and extracted. The risk of bias was evaluated using the Cochrane’s tool. Certainty of evidence was assessed as per the GRADE criteria. Forest plots were constructed to assess the effect size and corresponding 95% CIs using fixed-effect models, and random-effect models were employed when required. The primary outcome was the activity limitation measured by validated tools, such as the revised ALS Functional Rating Scale. Results: Twenty studies ( N = 1,218) were eligible. Of these, only five studies were double-blinded, and two were placebo-controlled. Fourteen HMs (fifty-one single botanicals) were involved; Astragalus mongholicus Bunge, Atractylodes macrocephala Koidz., and Glycyrrhiza glabra L. were commonly used in nine, eight, and six trials, respectively. For delaying activity limitation, Jiweiling injection (MD, 2.84; 95% CI, 1.21 to 4.46; p = 0.0006) and Shenmai injection (SMD, 1.07; 0.69 to 1.45; p &lt; 0.00001) were significantly more efficacious than Riluzole, but the evidence was low quality. For ameliorating motor neuron loss, Jiweiling injection [right abductor pollicis brevis (APB): MD, 32.42; 7.91 to 56.93; p = 0.01 and left APB: MD, 34.44; 12.85 to 56.03; p = 0.002] was favoured, but the evidence was very low quality. Nine studies reported one hundred and twenty-three adverse events, twenty-six of which occurred in the treatment groups and ninety-seven in the control groups. Conclusion: Very low to low quality of evidence suggests that HMs seem to produce superior treatment responses for ALS without increased risk of adverse events. Additional studies with homogeneous participants, reduced methodological issues, and more efficient outcome measures are required to provide confirmatory evidence. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD42021277443." @default.
• W4293740503 created "2022-08-31" @default.
• W4293740503 creator A5009582070 @default.
• W4293740503 creator A5013936186 @default.
• W4293740503 creator A5024136505 @default.
• W4293740503 creator A5026274455 @default.
• W4293740503 creator A5057117256 @default.
• W4293740503 creator A5062802638 @default.
• W4293740503 creator A5068062153 @default.
• W4293740503 creator A5083075571 @default.
• W4293740503 creator A5086125218 @default.
• W4293740503 date "2022-08-31" @default.
• W4293740503 modified "2023-10-14" @default.
• W4293740503 title "Herbal medicine for amyotrophic lateral sclerosis: A systematic review and meta-analysis" @default.
• W4293740503 cites W1580068968 @default.
• W4293740503 cites W1964177214 @default.
• W4293740503 cites W1966318487 @default.
• W4293740503 cites W2019840264 @default.
• W4293740503 cites W2030057835 @default.
• W4293740503 cites W2037377025 @default.
• W4293740503 cites W2044448185 @default.
• W4293740503 cites W2085165928 @default.
• W4293740503 cites W2089038365 @default.
• W4293740503 cites W2104744657 @default.
• W4293740503 cites W2108381339 @default.
• W4293740503 cites W2119390360 @default.
• W4293740503 cites W2139560421 @default.
• W4293740503 cites W2142064395 @default.
• W4293740503 cites W2142241246 @default.
• W4293740503 cites W2144536780 @default.
• W4293740503 cites W2146404696 @default.
• W4293740503 cites W2160809902 @default.
• W4293740503 cites W2161938104 @default.
• W4293740503 cites W2163119148 @default.
• W4293740503 cites W2314689571 @default.
• W4293740503 cites W2339648830 @default.
• W4293740503 cites W2616124858 @default.
• W4293740503 cites W2794654744 @default.
• W4293740503 cites W2807002945 @default.
• W4293740503 cites W2883918859 @default.
• W4293740503 cites W2884528651 @default.
• W4293740503 cites W2884621959 @default.
• W4293740503 cites W2905561928 @default.
• W4293740503 cites W2961326765 @default.
• W4293740503 cites W2970684805 @default.
• W4293740503 cites W3015372504 @default.
• W4293740503 cites W3030353689 @default.
• W4293740503 cites W3081033880 @default.
• W4293740503 cites W3082122716 @default.
• W4293740503 cites W3115439136 @default.
• W4293740503 cites W3118615836 @default.
• W4293740503 cites W3183534540 @default.
• W4293740503 cites W3207414509 @default.
• W4293740503 cites W3208849487 @default.
• W4293740503 cites W3210157956 @default.
• W4293740503 cites W4237126259 @default.
• W4293740503 cites W4252979096 @default.
• W4293740503 cites W4253195788 @default.
• W4293740503 cites W4292806894 @default.
• W4293740503 cites W4300753829 @default.
• W4293740503 doi "https://doi.org/10.3389/fphar.2022.946548" @default.
• W4293740503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36120351" @default.
• W4293740503 hasPublicationYear "2022" @default.
• W4293740503 type Work @default.
• W4293740503 citedByCount "0" @default.
• W4293740503 crossrefType "journal-article" @default.
• W4293740503 hasAuthorship W4293740503A5009582070 @default.
• W4293740503 hasAuthorship W4293740503A5013936186 @default.
• W4293740503 hasAuthorship W4293740503A5024136505 @default.
• W4293740503 hasAuthorship W4293740503A5026274455 @default.
• W4293740503 hasAuthorship W4293740503A5057117256 @default.
• W4293740503 hasAuthorship W4293740503A5062802638 @default.
• W4293740503 hasAuthorship W4293740503A5068062153 @default.
• W4293740503 hasAuthorship W4293740503A5083075571 @default.
• W4293740503 hasAuthorship W4293740503A5086125218 @default.
• W4293740503 hasBestOaLocation W42937405031 @default.
• W4293740503 hasConcept C126322002 @default.
• W4293740503 hasConcept C142724271 @default.
• W4293740503 hasConcept C168563851 @default.
• W4293740503 hasConcept C1862650 @default.
• W4293740503 hasConcept C197934379 @default.
• W4293740503 hasConcept C204787440 @default.
• W4293740503 hasConcept C27081682 @default.
• W4293740503 hasConcept C2779134260 @default.
• W4293740503 hasConcept C2779319286 @default.
• W4293740503 hasConcept C2780596555 @default.
• W4293740503 hasConcept C535046627 @default.
• W4293740503 hasConcept C556039675 @default.
• W4293740503 hasConcept C71924100 @default.
• W4293740503 hasConcept C95190672 @default.
• W4293740503 hasConceptScore W4293740503C126322002 @default.
• W4293740503 hasConceptScore W4293740503C142724271 @default.
• W4293740503 hasConceptScore W4293740503C168563851 @default.
• W4293740503 hasConceptScore W4293740503C1862650 @default.
• W4293740503 hasConceptScore W4293740503C197934379 @default.
• W4293740503 hasConceptScore W4293740503C204787440 @default.
• W4293740503 hasConceptScore W4293740503C27081682 @default.
• W4293740503 hasConceptScore W4293740503C2779134260 @default.
• W4293740503 hasConceptScore W4293740503C2779319286 @default.
• W4293740503 hasConceptScore W4293740503C2780596555 @default.

• next